Gene therapy for choroideremia: progress, potential and pitfalls

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Choroideremia is a rare, high-burden retinal disease.
• Gene-supplementation therapy represents a successful gene therapy approach for choroideremia.

Purpose of the Study:

• To review current gene therapy trial progress for choroideremia.
• To identify potential benefits and challenges of these trials.
• To propose a novel clinical endpoint for regulatory approval and recommend surgical technique optimization.

Main Methods:

• Review of current gene therapy trials for choroideremia.
• Analysis of clinical trial data, focusing on vector design, delivery, patient selection, and safety.
• Proposal of a novel clinical endpoint and surgical technique recommendations.

Main Results:

• Gene therapy for choroideremia has shown success.
• Phase 3 trial insights offer guidance for future treatments.
• Optimization of vector design, delivery, patient selection, and safety is crucial.

Conclusions:

• Gene therapy holds significant potential for treating choroideremia.
• Learnings from choroideremia trials can inform the development of therapies for polygenic retinal disorders.
• Further optimization of surgical techniques and clinical endpoints is recommended for regulatory success.